Los Angeles Capital Management LLC Nektar Therapeutics Transaction History

Los Angeles Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 05, 2018	SELL	$46.46 - $68.49 $3.82 Million - $5.64 Million	-82,325 Closed	0 $0
Q2 2018 Jul 31, 2018	SELL	$46.25 - $104.45 $259,832 - $586,800	-5,618 Reduced 6.39%	82,325 $4.02 Million
Q1 2018 Apr 27, 2018	BUY	$57.4 - $108.44 $2.81 Million - $5.3 Million	48,873 Added 125.09%	87,943 $9.35 Million
Q4 2017 Feb 05, 2018	BUY	$23.02 - $60.5 $615,324 - $1.62 Million	26,730 Added 216.61%	39,070 $2.33 Million
Q3 2017 Nov 06, 2017	BUY	$17.79 - $24.0 $219,528 - $296,160	12,340	12,340 $296,000

126

109M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $259M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.